The Swiss Connection

Send us a textLost cells on Apple, Spotify and any where you listen to your podcasts. SWI swissinfo.ch is a public service media company based in Bern, Switzerland.

Send us a textWant a longer life that still feels like yours? We sit down with psychologist Christina Röcke of the University of Zurich’s Healthy Longevity Center to unpack what actually fuels healthy aging—and what’s just marketing noise. From blue-zone myths to AI-driven biohacking, we trace why the longevity boom exploded and where the evidence really points: consistent movement, quality relationships, realistic stress strategies, and communities that make healthy choices simple.Join Swissinfo for a debate on this topic or read more of our science stories,  by visiting our website swisinfo.ch. You can help other people to find our podcast by leaving us a five-star review.Journalist: Jessica Davis PlüssHost: Jo FahyAudio editor/video journalist: Michele AndinaDistribution and Marketing: Xin ZhangSWI swissinfo.ch is a public service media company based in Bern, Switzerland.

Send us a textWe trace how a soil-derived drug led to the discovery of mTOR, why growth control sits at the core of aging biology, and where evidence ends for humans. Michael Hall’s quiet breakthroughs explain fasting, autophagy, and rapamycin without the hype.To read more about this topic and for more science stories, visit our website swisinfo.ch. You can help other people to find our podcast by leaving us a five-star review.Journalist: Jessica Davis PlüssHost: Jo FahyAudio editor/video journalist: Michele AndinaDistribution and Marketing: Xin ZhangSWI swissinfo.ch is a public service media company based in Bern, Switzerland.

Send us a textWhat if the most valuable drug candidates aren’t found but designed on demand? We follow a chemist’s journey from a pencil-and-paper notebook to generative algorithms that propose novel, IP-free molecules tailored to specific targets, and we open the door to how Swiss pharma is rebuilding discovery around AI.To read more about this topic and for more science stories, visit our website swisinfo.ch. You can help other people to find our podcast by leaving us a five-star review.Journalist: Jessica Davis PlüssHost: Jo FahyAudio editor/video journalist: Michele AndinaDistribution and Marketing: Xin ZhangSWI swissinfo.ch is a public service media company based in Bern, Switzerland.

Send us a textWe trace how sex and gender shape drug development, from male-heavy mouse studies to the split results in Lecanemab’s Alzheimer’s trial. Experts explain why regulators should keep approvals moving while demanding smarter design, better reporting, and post-approval answers. For more science stories, visit our website swisinfo.ch, and you can help other people to find our podcast by leaving us a five-star review.Journalist: Jessica Davis PlüssHost: Jo FahyAudio editor/video journalist: Michele AndinaDistribution and Marketing: Xin ZhangSWI swissinfo.ch is a public service media company based in Bern, Switzerland.